logo
Start With the Why: Easing Fears of Cardiac Testing

Start With the Why: Easing Fears of Cardiac Testing

Medscape07-07-2025
It's common for patients to schedule an office visit due to symptoms like shortness of breath from doing regular tasks, feeling heart palpitations, experiencing mild chest pain, or feeling weak or unusually tired.
During your assessment, if you determine that the patient has an irregular heartbeat, a family history of cardiac conditions, or believe further testing is warranted, realize that a patient could be fearful of cardiac testing. To ease the concerns of your patients, it's important to explain how such testing can diagnose the reason they aren't feeling quite right and how their treatment team can help them feel better.
Start With the Why
Leaving the trusted environment of a primary care office can be daunting for patients, particularly for those who haven't had cardiac testing before. But explaining why you're suggesting the tests can help a patient understand.
"The most important step would be to explain how cardiac testing can be important in order to screen for issues before they become serious," said David Weininger Cohen, MD, a cardiologist with the Leonard M. Miller School of Medicine at the University of Miami in Florida.
He also suggested recounting what symptoms patients are experiencing and how specific tests can investigate what's causing them. Also, explaining that some symptoms may not even be tied to cardiac issues could be another strategy to demonstrate the importance of further testing.
"For instance, chest pain is a symptom that becomes a common reason for visits. Most people usually associate chest pain with heart issues, but there are a lot of structures in the chest that can cause pain, not just the heart — cartilage, esophagus, sometimes part of the stomach, skin, and even nerve endings," he said. "Ultimately, cardiac testing is important because it allows the physician to discriminate between cardiac and non-cardiac causes for the patient's symptoms."
In addition, reassuring your patients that these experts can diagnose potential issues may also ease their worries, so articulate how such cardiac tests are performed in a controlled environment with trained staff that can anticipate issues and respond quickly if something goes wrong, Weininger Cohen added.
Understand Patients Are Fearful of Test Results
Some patients are afraid of the results as much as the test.
"In those cases, I like to reinforce why the test is necessary and why we're doing it," said Weininger Cohen. "Additionally, I sometimes go through the possible scenarios depending on the results of each test." Knowing what lies ahead, depending on what the test shows, can sometimes be reassuring — you're showing patients you know exactly what the next steps would be.
Treat Fears Patient by Patient
Although there are some general practice strategies to ease fear regarding cardiac testing, personalizing your approach is also important.
"The best way to tackle fear of cardiac testing would be to ask the patient exactly what they're afraid of," said Weininger Cohen. Some patients are going to be afraid of having pain or discomfort during the test. Some patients are afraid of what the results may be, and some patients are afraid of possible complications.
"Usually, the best way to approach the topic is to explain the reason for the test and then address the specific fear the patient has," he specified.
For example, the best way to describe an EKG would be to explain that it is a test that is trying to capture the electrical activity of the heart. To achieve that, the person performing it is putting sensors on different parts of the patient's body to detect the heart's electrical current from different points, he said. Emphasizing that the test is painless, and that it's just capturing the natural electrical activity of the heart, should put patients at ease.
How Can You Best Describe an Echocardiogram?
Most patients understand what an ultrasound is, so advising patients that an echocardiogram is simply an ultrasound study of the heart can calm fears. It may also be helpful to share that in some cases, ultrasounds use enhancing agents, referred to as contrast, to get a look at the different structures of the heart, he said.
Some patients could be concerned about radiation.
"Both tests are radiation free, and this is something that some patients are very interested in knowing before proceeding, especially if they have been previously exposed to radiation through other diagnostic imaging tests or radiotherapy for cancer treatment," Weininger Cohen said. Taking the time to explain both an echocardiogram and an EKG can help your patients understand what to expect and reduce worry and the fear of the unknown.
What to Tell Patients Before Referring to a Cardiologist
Referring a patient to a specialist like a cardiologist could cause fear. So explain why you're taking this step.
Mustafa M. Ahmed, MD
"Telling a patient why they need to see a heart expert and how they will add to their overall care can be a helpful first step," said Mustafa M. Ahmed, MD, a cardiologist and professor of medicine, who's also vice chief of research of the Division of Cardiovascular Medicine and medical director of the Mechanical Circulatory Support Program at the University of Florida in Gainesville. "Assuring them that they won't be losing their primary care doctor, but gaining a specialist to consult with both them and the primary care team, is often a good way to frame expectations."
Lifestyle Tweaks You Might Suggest
In the context of your discussions with patients regarding their symptoms and recommendations for cardiac testing, Ahmed suggested expressing how diet and exercise, as a part of overall lifestyle changes, can be the most impactful way to prevent heart disease.
"Gentle guidance and step-by-step encouragement are often helpful," he said.
Also, involving other family members and friends in that journey is another strategy. This may include taking walks, preparing meals together, or embracing a healthier mindset overall.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure
Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure

Yahoo

time12 minutes ago

  • Yahoo

Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure

Seattle Plastic Surgeon Performs Nation's First Combined Facial Feminization & Hair Transplant Surgery SEATTLE, WA / / August 5, 2025 / Dr. Javad Sajan, a top Seattle plastic surgeon and founder of Allure Esthetic Plastic Surgery, has made medical history in the U.S. by performing the nation's first facial feminization surgery (FFS) combined with hair transplant in a single operative session. The milestone procedure was performed on Ember Norman and is featured on offering a detailed look at the surgical planning, technique, and outcomes. The entire surgery, including the hair transplant, qualified for coverage under Norman's gender‑affirming insurance plan. As part of a full facial feminization surgery, Dr. Javad Sajan performed a carefully planned combination of skeletal and soft tissue procedures to transform the patient's facial structure and features. The surgery began with upper facial bone contouring, including frontal bone and orbital bone reduction, and a frontal sinus setback to soften and feminize the upper third of the face. A follicular unit transplant of 1,000 grafts was performed to feminize the hairline. To further feminize the upper face, Dr. Sajan performed a brow lift, elevating the brow position for a more open and feminine expression. In the midface, a mid-facelift and rhinoplasty were performed to enhance facial harmony and refine nasal shape and projection. For the lower face, Dr. Sajan completed a lip lift to shorten the philtrum and improve lip aesthetics. This was followed by chin bone reduction and jaw bone reduction to narrow and sculpt the lower facial contour. This comprehensive transformation reflects the precision and artistry involved in advanced facial feminization surgery. The full surgical journey and before-and-after results can be viewed here. These combined procedures eliminate the need for a second surgery, making the healing process easier and more efficient. Key benefits of this approach include: Single anesthesia event and one recovery timeline A lower and more feminine hairline Minimal scarring Who is an ideal candidate for a same-day FFS+ hair transplant? Ideal candidates for simultaneous FFS and hair transplant surgery include healthy transgender or non-binary patients who are medically cleared for general anesthesia, have realistic expectations, and maintain stable hormone levels for at least six months. Is combining the procedures safe? Combining both procedures in a single session is generally safe; however, all surgery and anesthesia have risks. It eliminates the need for a second anesthesia event, minimizes cumulative swelling, and avoids re-entering previously operated areas, such as a freshly feminized forehead, during a later surgery. How long does the surgery take? The combined procedure typically takes 6 to 12 hours, depending on the extent of facial bone reshaping and the number of hair grafts required. About Dr. Javad Sajan and Allure Esthetic Plastic Surgery: Dr. Javad Sajan is a renowned Seattle-based plastic surgeon, known for his leadership in gender-affirming and facial cosmetic surgery. At Allure Esthetic, Dr. Sajan and his team blend advanced techniques with personalized care to deliver exceptional results. Media Contact:Allure Esthetic Plastic SurgeryPhone: 206-209-0988Website: info@ SOURCE: RealDrSeattle View the original press release on ACCESS Newswire Sign in to access your portfolio

Why Hims & Hers Health Stock Just Dropped
Why Hims & Hers Health Stock Just Dropped

Yahoo

time12 minutes ago

  • Yahoo

Why Hims & Hers Health Stock Just Dropped

Key Points Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street wanted more. Hims & Hers also reported negative free cash flow for the first half of the year. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling today, down 6.7% through 10:55 a.m. ET after missing in its second-quarter earnings report last night, on both the top and bottom lines. Heading into the report, analysts forecast Hims & Hers would earn $0.23 per share on $552 million in sales -- but Hims & Hers earned only $0.17 per share, and sales were less than $545 million. Hims & Hers' Q2 earnings But was the news really as bad as it seems? After all, while Hims & Hers "missed" on sales, it did still grow sales 73% year over year. That was twice as fast as it grew subscribers, too (31%), indicating that not only are more customers signing up for the company's services, but they're buying more, too. And while Hims & Hers missed on earnings, too, those earnings per share nearly tripled year over year. Really, the only "bad" number I see in the report concerns free cash flow (FCF). Through the first half of this year, Hims & Hers grew its operating cash flow only 13%, to $90 million (within a couple of percentage points of reported net income). However, the company spent massively on capital expenditures -- more than $100 million -- resulting in negative FCF for the first half of 2025. Investors seem unsure what to make of the news. At one point this morning, the stock had recovered all its losses, and even turned green, before falling back into the red. Is Hims & Hers stock a sell? So how should investors react to this conflicting news? At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more expensive when valued on FCF -- about 103 times. These might be acceptable valuations if earnings were to continue tripling year after year. In fact, though, analysts see profits growing only 13% this year, and perhaps 57% next. For the time being, Hims & Hers stock remains too expensive to buy. Should you buy stock in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Why Hims & Hers Health Stock Just Dropped was originally published by The Motley Fool

Multiple infections linked to raw milk consumption in Florida, health officials say
Multiple infections linked to raw milk consumption in Florida, health officials say

Yahoo

time12 minutes ago

  • Yahoo

Multiple infections linked to raw milk consumption in Florida, health officials say

The Florida Department of Health is investigating an outbreak of infections linked to drinking unpasteurized milk, officials said this week. The health department issued a bulletin Monday, reporting that 21 people who consumed raw milk from the same farm had been infected with campylobacter and E. coli, with seven of those patients requiring hospitalization. Of the 21 cases, six were children under the age of 10. "Severe complications have been reported for at least two cases," officials said. The health department did not name the farm that produced the raw milk but confirmed the ingredient was linked to the cases. It is illegal to sell raw milk for human consumption in Florida. Raw milk can legally be sold for non-human consumption "as pet or animal food," the health department stated, because it doesn't undergo the same sanitary regulations and can be a source of foodborne illness. "Due to continued recent cases of Campylobacter and Shiga toxin-producing E. coli (STEC) infections linked to a particular farm, the Florida Department of Health is providing information to assist Floridians in making informed decisions about their health," Monday's health alert stated. "Sanitation practices in this farm are of particular concern due to the number of cases." This is a developing story. Please check back for more details. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store